Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors
This was the stock's second consecutive day of losses.
Zacks Investment Research on MSN1d
After Plunging -22.69% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)
Corbus Pharmaceuticals (CRBP) has been on a downward spiral lately with significant selling pressure. After declining 22.7% ...
Corbus Pharmaceuticals (NASDAQ:CRBP) Receives Outperform Rating from Wedbush
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at ...
Corbus Pharmaceuticals price target lowered to $50 from $75 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Corbus Pharmaceuticals (CRBP) to $50 from $75 and keeps a Buy rating on the shares. The firm ...
Corbus Pharmaceuticals (CRBP) Gets a Buy from William Blair
William Blair analyst Andy Hsieh reiterated a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) today. The company’s shares opened ...
Investing3d
Corbus Pharmaceuticals appoints new COO
Corbus Pharmaceuticals Holdings ... with InvestingPro analysis showing the stock has declined over 83% in the past year, currently trading near its 52-week low of $6.38. The company’s filing ...
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors
The stock's fall snapped a two-day winning streak.
Yahoo Finance2d
After Plunging -22.9% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)
Corbus Pharmaceuticals (CRBP) has been on a downward spiral lately with significant selling pressure. After declining 22.9% over the past four weeks, the stock looks well positioned for a trend ...